Congenital infection with cytomegalovirus (CMV) is the main cause of sensorineural hearing loss and psychomotor impairment which can develop at birth or later in infant's life. Because of a lack of nation-wide serological screening for pregnant women and accepted antiviral therapy during pregnancy in a high seroprevalence rate population of Poland, we introduced the regional screening programme for CMV infection in neonates from the Poznan Province to diminish a risk of the symptomatic disease. The aims of the study were: (i) to determine the prevalence of specific anti-CMV antibodies in populations of pregnant women and newborns from the Poznan area, (ii) to increase the early postnatal detection of congenital CMV infections, and (iii) to evaluate a risk of perinatal or early postnatal infections with CMV in newborns or infants born to seropositive mothers. Serological testing was performed in 4.192 live born neonates, using dried blood filter-paper specimens. The seropositivity rate in the studied population of neonates and pregnant women was 78.6%. The incidence of perinatal and early postnatal CMV infections was evaluated to be 3.1% or 1 per 25 neonates born to seropositive mothers. Congenital CMV infections confirmed by a presence of specific IgM antibodies were diagnosed in 5 newborns, which represent 1 case per 838 successive deliveries. In a clinical pattern of cytomegalovirus disease respiratory disorders and low birth weight were most frequently observed, and neurological signs, hepatitis, haemorrhagies or jaundice were sporadically diagnosed.
INTRODUCTION
Cytomegalovirus, species specific for humans (HCMV -Human Cytomegalovirus), is the most frequent cause of congenital viral infections, which proceeds with a significant risk of developing a symptomatic disease in a foetus, a newborn, an infant or in an older child [1] . The incidence of congenital CMV infection detected in newborns differs according to a geographical area, and some environmental or socio-economical conditions of populations living in particular regions of the world, and ranges between 0.2 to 2.5% (mean 1%) [2] .
A transplacental transmission of CMV can be caused either by a primary infection of a child's mother during her pregnancy, and by a reinfection or a late reactivation of the disease. A secondary infection with the CMV in a pregnant woman can be related to a reactivation of previously acquired, latent infection or can take place as a result of a reinfection with a different strain of the virus of a higher pathogenecity [2] . However, the incidence of congenital cytomegaly in a foetus as a sequel of a primary maternal infection during pregnancy is significantly much higher (40-50%) than in a case of a recurrent infection with the virus in a CMV-seropositive mother (less than 1%) [3] .
A primary CMV infection occurs in 0.7 -4.1% of all pregnant women, with a risk of a transplacental transmission to a foetus which varies between 24 to 75% (mean 40%). Although most of children with congenital CMV infection born to mothers infected for the first time during pregnancy do not present any clinical symptoms at birth, a risk of developing a symptomatic cytomegaloviral disease is much higher comparing to a reinfection or a reactivation of CMV infection in a mother in her pregnancy [3] [4] [5] . As opposed to rubella or toxoplasmosis, the fact of having specific anti-CMV antibodies in the peripheral blood during pregnancy does not make an efficient immunological protection against a possible risk of a materno-foetal transmission of infection [6] . In countries, where majority of women in a childbearing age group show a very high percentage of seropositivity, the incidence of congenital CMV infection is significantly much higher than in areas, where acquired cytomegaly occurs rarer in a population. There has not been found any relation between a high seroprevalence in a particular population of pregnant women in a given geographical area and an incidence of a clinically overt form of CMV infection in newborns [3] .
A transplacental transmission of CMV during pregnancy is a consequence of maternal viraemia, with the same incidence in each of its trimestres. Similarly, congenital cytomegaly may occur any time during the prenatal period, although severe neurological symptoms are more often seen in neonates when their mothers are infected in a second half of pregnancy [4] .
CMV infection can also be transmitted in the perinatal period by a direct contact with secretions of an infected mother (saliva, breast milk, mucus of uterine cervix). It was reported, that mothers with positive levels of specific anti-CMV IgG antibody, more often secrete the virus in their milk, and that is why even up to 53% of infants breast-fed by seropositive mothers can be infected with CMV in the neonatal or infant's periods [7] . So far, an actual incidence of pre-and perinatal CMV infections in Poland has not been precisely evaluated, and reported data were usually estimated on a number of registered deaths and selected severe cases of symptomatic cytomegaly. Based on a health minister decree "about infectious diseases and infections" dated on 6 th of August 2001, CMV infection in Poland is a subject to a duty of a strict registration.
On the ground of monthly epidemiological reports of the National Institute of Hygiene There is no obligatory systematical serological testing for CMV-specific antibodies in a pregnant women population in Poland yet and rarely performed tests in obstetric clinics are not usually consulted by specialists of infectious diseases.
Taking under a consideration a significant risk of congenital cytomegaly in a country with a high level of seroprevalence, the University Centre in Poznan (Poland) decided to conduct a pilote regional screening programme for newborns with a purpose of decreasing a risk of a patent form of the CMV infection. In the age of obligatory screening tests which are routinely performed in neonates using a few drops of the blood taken on a filter-paper card (Guthrie card), a detection of CMV infection combined to other tests for more than 20 different metabolic disorders and other congenital malformations, including TORCH infections, seems to be a modern way of a third line prevention strategy that is actually recommended all over the world [8] .
The aims of the new immunodiagnostic study were: (i) to determine the were included into the pilote study (Kalisz, Kolo, Ostrow Wielkopolski, Poznan, Pila, Szamotuly, Srem, Trzcianka). As maternal immunoglobulin G antibody is passively transmitted through the placenta to a foetus, analysis of a total level of CMV-specific antibodies in neonatal filter-paper spots collected at birth was therefore considered as an equivalent to the seropositivity rate in a pregnant women population at delivery time.
Peripheral capillary blood was collected from newborns in neonatal wards during their first 3 days of life or by nurses at home using a low invasive heel puncture, and diseases and prenatally acquired infections including TORCH (Fig. 1) . The procedure of a detection of actively synthesized anti-CMV IgM antibody in eluates from 3.2-mm filter-paper blood spots was very similar to that detecting a total level of CMV-specific antibodies described in the pilote study, exept use of secondary rabbit anti-human IgM antibody specific for µ chain and conjugated with alkaline phosphatase (Dako, Glostrup, Denmark). CMV-positive and negative standard sera were applied as controls to every assay run in four separate wells (Institute Virion, Ruschlikon, Switzerland). A result of the IgM screening test was considered as positive when optical density (OD) of the analyzed filter-paper sample was higher than a mean OD value of a negative control sample plus 3 standard deviations (SD) [11] .
Congenital CMV infection was finally confirmed by (i) a detection of actively (Fig. 2) .
Clinical assessment.
In the neonates with confirmed CMV infections a paediatric examination, of pregnancy (mean 38.6 ± 1.9 weeks); in 5 cases there were operative deliveries solved by caesarean section (n=3) or by using a vacuum extractor in 34-40 weeks (mean 37.4 ± 2.7 weeks) of pregnancy (n=2). During a serological follow-up of these patients, which was performed for 1 to 27 weeks after birth (mean 18 weeks), three of the 16 CMV infected children showed a presence of specific IgM antibody (which does not cross the placenta), persisting over the first month of the age, two patients were diagnosed to have significantly higher levels of IgG than their mothers did, which were stable through the whole serological observation time, in 10 infants there was observed a significant increase in a level of specific IgG antibody during the first year of life, while in one patient with a temporary negativisation of CMV-specific IgG antibody between 3. and 5. month of life, a serological rebound was observed at the age of six months. All mothers of infected neonates showed very high levels of anti-CMV specific IgG antibody, whereas only 3 of them were still IgM-positive after delivery.
A total incidence of perinatal and early postnatal CMV infections, which was evaluated in the pilote study, appeared to be significantly high and was estimated as shown by a Western blot technique revealed that in 3 children congenital cytomegaly was a consequence of a reactivation of CMV infection that had been undergone previously, while in the remaining two neonates the congenital disease was a sequel of a primary viral infection acquired by a child's mother during her pregnancy (Fig. 2) .
Furthermore, 38 filter-paper samples collected from neonates in the first days of life during their stay at hospital wards required re-testing for verifying analysis because of doubtful results of the screening IgM test (0.91%).
Data referring to delivery and some clinical features of the 5 neonates with confirmed congenital CMV infection are shown in Table II . In three children, clinically overt form of CMV infection was diagnosed (characteristics of preterm birth and/or small gestational age, jaundice, thrombocytopenic purpura, pneumonia, neurological disorders) but in the remaining two children -only subclinical CMV infection recognized by a specific antibody response to the virus was observed.
As a number of foetal losses related to CMV remains unknown, the incidence of infections some routine microbiological techniques of a cell culture of the virus from saliva or urine, collected in the first day of life of a neonate, are usually performed [13] [14] [15] [16] . Blood samples absorbed on filter-papers have only been used in some populational studies of newborns in Italy and Brazil to detect the specific immunological response against CMV or fragments of nucleic acids of the virus [17] [18] [19] [20] . Detection of cytomegalovirus DNA extracted from neonatal filter-paper cards collected at birth was being considered as a competitive method to serological neonatal screening but it seems to play a bigger role in individual patients at risk of infection, like among newborns with sensorineural hearing loss, retinal lesions and neurological impairment or in cases with some congenital malformations, more than in screening populational tests [19, 20] . Most of the tests for congenital CMV performed in neonates are considered for selected cases, who are strongly suspected of having infection from a TORCH group, so the mass nation-wide or regional screening programmes are performed sporadically. In Finland, a screening test for CMV was performed in neonates who were born prematurely before 34 weeks of gestation. In this selected group, the authors got a high percentage of serologically confirmed congenital CMV infection which reached 4.8% [14] . Similarly, Barbi and colleagues (1998) reported that a prevalence of congenital CMV infection was 10 times higher in neonates from a risk group presenting some symptoms of intrauterine infection (5%), than in a total group of children who were born successively (0.47%). Molecular biology techniques were recommended to make a final confirmation of suspected cases of congenital CMV infection, detected by a traditional culture of the virus isolated from saliva [18] . Moreover, analysis of specific IgM antibody in eluates from neonatal Guthrie cards by ELISA seemed to have diagnostic sensitivity and specificity comparable to this, which is shown by a PCR technique adapted to a detection of DNA in the blood absorbed on filter-papers [21] .
A rational decision about a necessity of embracing a whole population of neonates by screening tests should be preceded by epidemiological analysis of the incidence of a particular disease with a congenital etiology and its potential risk on the evaluated geographical region to select the most optimal preventive strategy for a particular area of the word. That is a reason why the neonatal screening programme, as an effective method for a prevention of clinically overt congenital cytomegaly was decided to be implemented in the West Poland Province in a high seroprevalence population of women in a procreative age with a small risk of primary CMV infections during pregnancy.
On the basis of the pilote seroepidemiological study performed by the Poznan
Centre in a sample of 513 neonates from the West Poland Province, we have found a high incidence of positive levels of specific anti-CMV antibodies in a population of women who give birth that was 78.6%. The Poznan area was described as a region of a high seropositivity for CMV in pregnant women and a significant risk of transplacental transmission of the infection to a foetus. So there was a justifiable assumption, that a risk of congenital CMV infection in our country is proportionally much higher than it had been suspected to be before, based on sporadically noted severe cases of symptomatic cytomegaly. of them had been infected between 3. and 7. week of life [23] . Similar study conducted at the University in Toronto showed that 6.2% of children born to seropositive mothers got infected by CMV in the age of 7-11 weeks [24] . Among significant risk factors promoting postnatal CMV infection there were mentioned:
spontaneous delivery, pregnancy terminated before 34 weeks of gestational age, and long-term or begun in the neonatal period breast-feeding [25] . Schanler (2005) described that postnatal infection with CMV is typical for premature neonates of about 1. month of the age and usually has a form of latent infection, while symptomatic cytomegaloviral disease, which resembles a severe generalized form imitating sepsis occurs sporadically [26] .
Cytomegaly should be more often considered in a differential diagnosis of 
